Lataa...
Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure
BACKGROUND: Ranolazine (RAN) reduces cardiac sodium channel 1.5’s late sodium current in congestive heart failure (CHF), reducing myocardial calcium overload, potentially improving left ventricular (LV) function. RAN blocks neuronal sodium channel 1.7, potentially altering parasympathetic and sympat...
Tallennettuna:
| Julkaisussa: | Heart Int |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wichtig
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774941/ https://ncbi.nlm.nih.gov/pubmed/27004101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/heartint.5000219 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|